Stabilitech Ltd, a privately-held UK company that is developing a technique for enabling temperature-sensitive vaccines and biopharmaceuticals to be kept without refrigeration, has appointed Donna Hackett as its commercial director.
Ms Hackett was previously a partner with ProPharma Partners, a consultancy specialising in preclinical, clinical and regulatory advice. She has an honours degree in biochemistry from the University of Aberdeen, a diploma in management studies and is a qualified but non-practising barrister.
Copyright 2011 Evernow Publishing Ltd